BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15343583)

  • 1. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification.
    Schalkwijk CG; Stehouwer CD; van Hinsbergh VW
    Diabetes Metab Res Rev; 2004; 20(5):369-82. PubMed ID: 15343583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental studies on the role of fructose in the development of diabetic complications.
    Sakai M; Oimomi M; Kasuga M
    Kobe J Med Sci; 2002 Dec; 48(5-6):125-36. PubMed ID: 12594356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
    Szwergold BS
    Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fructose on collagen glycation.
    Oimomi M; Sakai M; Ohara T; Igaki N; Nakamichi T; Nishimoto S; Hata F; Baba S
    Kobe J Med Sci; 1989 Aug; 35(4):195-200. PubMed ID: 2517637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management.
    Rajasekar P; Anuradha CV
    Acta Diabetol; 2007 Jun; 44(2):83-90. PubMed ID: 17530472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonenzymatic browning of proteins and the sorbitol pathway.
    Suarez G
    Prog Clin Biol Res; 1989; 304():141-62. PubMed ID: 2675027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylglyoxal: its presence in beverages and potential scavengers.
    Tan D; Wang Y; Lo CY; Sang S; Ho CT
    Ann N Y Acad Sci; 2008 Apr; 1126():72-5. PubMed ID: 18448797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally occurring inhibitors against the formation of advanced glycation end-products.
    Peng X; Ma J; Chen F; Wang M
    Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein glycation: creation of catalytic sites for free radical generation.
    Yim MB; Yim HS; Lee C; Kang SO; Chock PB
    Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.
    Vasan S; Zhang X; Zhang X; Kapurniotu A; Bernhagen J; Teichberg S; Basgen J; Wagle D; Shih D; Terlecky I; Bucala R; Cerami A; Egan J; Ulrich P
    Nature; 1996 Jul; 382(6588):275-8. PubMed ID: 8717046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of glycation to cataract formation in diabetes.
    Stevens A
    J Am Optom Assoc; 1998 Aug; 69(8):519-30. PubMed ID: 9747048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update.
    Lapolla A; Fedele D; Seraglia R; Traldi P
    Mass Spectrom Rev; 2006; 25(5):775-97. PubMed ID: 16625652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological detection of fructose-derived advanced glycation end-products.
    Takeuchi M; Iwaki M; Takino J; Shirai H; Kawakami M; Bucala R; Yamagishi S
    Lab Invest; 2010 Jul; 90(7):1117-27. PubMed ID: 20212455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose.
    Nakamura K; Nakazawa Y; Ienaga K
    Biochem Biophys Res Commun; 1997 Mar; 232(1):227-30. PubMed ID: 9125137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes.
    Peyroux J; Sternberg M
    Pathol Biol (Paris); 2006 Sep; 54(7):405-19. PubMed ID: 16978799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation endproducts and cigarette smoking.
    Nicholl ID; Bucala R
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1025-33. PubMed ID: 9846884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation of a lysine-containing tetrapeptide by D-glucose and D-fructose--influence of different reaction conditions on the formation of Amadori/Heyns products.
    Jakas A; Katić A; Bionda N; Horvat S
    Carbohydr Res; 2008 Sep; 343(14):2475-80. PubMed ID: 18656854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards the control and inhibition of glycation-the role of the guanidine reaction center with aldehydic and diketonic dicarbonyls. A mass spectrometry study.
    Saraiva MA; Borges CM; Florêncio MH
    J Mass Spectrom; 2006 Oct; 41(10):1346-68. PubMed ID: 17039581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.